NEWHALL CHARLES W III sold 0.7% of their position (1K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $45.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/27/2025ACC: 0001005544-25-000006
Director
Since Feb 2026
-1K
Net shares
Net seller
$45.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1K
Price / share
$45.00
Trade value
$45K
% of position
0.7%
8/25/2025
134.23K→133.23K
Total
Net shares
−1K
Net value
-$45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2025 | S · Sale | −1K | $45.00 | $45K | 0.7% | 134.23K | 133.23K |
| Total | −1K | -$45K | ||||||
Derivative Transactions0
No derivative transactions reported